Palmitoylation is the reversible addition of palmitate to cysteine via a thioester linkage. Following stimulation of the T-cell receptor we find a number of proteins are newly palmitoylated, including those involved in vesiclemediated transport and Ras signal transduction. Among these stimulation-dependent palmitoylation targets are the v-SNARE VAMP7, important for docking of vesicular LAT during TCR signaling, and the largely undescribed palmitoyl acyltransferase DHHC18 that is expressed in two isoforms in T cells. Using our newly developed On-Plate Palmitoylation Assay (OPPA), we show DHHC18 is capable of palmitoylating VAMP7 at Cys183. Cellular imaging shows that the palmitoylation-deficient protein fails to be retained at the Golgi.
palmitoylation candidates are involved in a variety of cellular processes (Fig. 2B) , notably Ras signal transduction, TCR signaling, and vesicle-mediated transport.
The OPPA method allows for rapid determination of steady-state palmitoylation rates.
To investigate these stimulation-dependent palmitoylation candidates in a controlled setting, we designed constructs of DHHC18, DHHC20, VAMP7, and LAT for expression in Sf9 insect cells (Fig 2A, Supp. Figs. 4,5) .
Although VAMP7 has been reported as palmitoylated in eight other human palmitome studies 23, 24, 27, 28, 30, 38, 39, 43, 47 , the site of its palmitoylation has not been described. Of the six cysteines in its primary sequence, we found three NEM-modified during our ABE enrichment (data not shown), suggesting they are not palmitoylated, while two others are located in the vesicular lumen, not accessible to a DHHC PAT's cytosolic active site; the remaining cysteine, Cys183, which is located in an optimal juxtamembrane position, was therefore chosen for mutational studies as the most likely site of palmitoylation 33 .
Likewise, in DHHC18, we sought to investigate the role the N-and C-terminal tails of DHHC18 might play in the enzyme's stability or activity by designing ΔN and ΔC domain constructs. Moreover, we designed a construct based on the truncated isoform 2 of DHHC18, which we previously hypothesized was preferentially palmitoylated in T cells 31 . Intriguingly, this isoform lacks the two N-terminal TMDs of the full-length protein, yet features a cysteine (Cys138) only three residues from its new N-terminus, which might represent a palmitoylation anchor to the membrane.
In order to improve upon the shortcomings of current in vitro palmitoylation assays, we developed the On-Plate Palmitoylation Assay (OPPA) method ( Fig 2B) . Briefly, purified substrates (e.g. VAMP7) bearing both His6and FLAG-tags are bound to Ni-NTA plates, to which purified DHHC PATs (lacking His6-tags) and clickable palmitic acid alkyne (PAA)-CoA are added. The palmitoylation reaction is quenched at specific time points by Nethylmaleimide (NEM), which both blocks the site of palmitoylation and the DHHC active-site cysteine. After washing, biotin-azide is clicked onto the palmitoylated substrate, which is subsequently eluted from the Ni-NTA plate and bound to anti-FLAG-coated plates. This allows the detection of the biotinylated substrate via fluorescence of Eu 3+ -streptavidin and the determination of the steady-state rate of palmitoylation.
Examining DHHC18 and DHHC20 activity by OPPA
Using the VAMP7 and LAT constructs as palmitoylation targets and the DHHC18 and DHHC20 constructs as palmitoylating enzymes allowed us to validate the OPPA method and investigate these reactions in vitro ( Fig   2C) . While autopalmitoylation of VAMP7 is minimal at 20 µM PAA-CoA (Supp. Figs 6-8 ), the rate of palmitoylation is greatly enhanced by full-length DHHC18. The active-site mutant DHHC18-C222A prevents this palmitoylation. DHHC20 was barely capable of palmitoylating VAMP7, while its active-site mutant C156A is also inactive.
Truncating either the N-or C-terminal tails of DHHC18 results in a significant decrease in the palmitoylation rate of VAMP7. Whether this speaks for a role in these cytosolic tails in substrate recognition or engagement, in its enzymatic mechanism, or in simply stabilizing the enzyme will require further investigation.
The short isoform DHHC18-2, lacking the N-terminal TMDs, is capable of palmitoylating VAMP7, albeit at a slightly decreased rate. Intriguingly, mutating the proposed palmitoylation anchor cysteine C138 to alanine prevents DHHC18-2's palmitoylation of VAMP7, while this mutation in full-length DHHC18-1 has no effect; one potential model to explain this is shown in Figure 2B .
Finally, LAT was used as a second palmitoylation target. Full-length DHHC18 was capable of palmitoylating LAT, while DHHC20 failed to do so. This may speak to a specificity for LAT palmitoylation by DHHC18 and not DHHC20. As DHHC20 is located at the PM and turnover of LAT palmitoylation is not expected to be rapid, the specificity of Golgi-localized DHHC18 could perhaps reflect a biological reality; this should be confirmed in a cellular context, perhaps with PAT-specific knockouts and subsequent palmitome enrichment, as was recently performed for DHHC13 45, 48 .
VAMP7 is palmitoylated at Cys183 in vitro and in vivo and is required for Golgi localization
The proposed palmitoylation site in VAMP7, Cys183, was also mutated to alanine. This prevented its palmitoylation by both DHHC18 and DHHC20, suggesting that this is indeed the primary site of in vitro palmitoylation. To confirm this in vivo, CRISPR/Cas9 knockout Jurkat cell lines with lentivirally transduced stable re-expression of VAMP7-WT and -C183A constructs were engineered (Supp. Fig. 10 ). Once generated, ABE was used to enrich all palmitoylated proteins in these cell lines. VAMP7 was found to be palmitoylated in the Jurkat E6.1 and VAMP7-WT re-expression cell lines, but not in the VAMP7 knockout or VAMP7-C183A re-expression cell lines, confirming that Cys183 is the site of VAMP7 palmitoylation in Jurkat T cells (Supp. Fig. 11 ).
The VAMP7-KO Jurkat cell lines stably expressing VAMP7-WT and VAMP7-C183A were analyzed by TIRFM to observe localization of these two constructs. The re-expressed VAMP7-WT, which is capable of being palmitoylated, is largely found in the Golgi of the VAMP7 knockout/re-expression Jurkat cells, in agreement with earlier observations ( Fig 4A) 49 . VAMP7-C183A, however, does not co-localize with the Golgi marker giantin, instead localizing to the cytosol, presumably within vesicles (Fig 3) . This supports the conclusion that palmitoylation of VAMP7 at Cys183 acts as a sorting signal for the Golgi 50, 51 . Mutating Cys183 prevents this localization, allowing a larger population of VAMP7 to localize to vesicles 11, 52 .
Since VAMP7 has been shown to control membrane trafficking from and to the Golgi 53 , mislocalization of the mutant form of VAMP7 may have some consequences on the trafficking of cargoes in T lymphocytes. It might also alter some cell functions such as polarized transport of proteins or cell migration. The fact that, as shown here, localization of this key v-SNARE protein is regulated upon TCR triggering reinforces the link that exists between TCR-induced signaling and intracellular trafficking 54 .
Materials and Methods

Jurkat Cell Culture and Stimulation
Jurkat T cells (clone E6-1) were grown in RPMI 1640 SILAC medium with 10% FCS at 37 ˚C and 5% CO2 (SILAC Quantification Kit, Pierce). Cells were stimulated using anti-CD3 IgM (C305) and anti-CD28 IgM hybridoma supernatants in RPMI without FCS at 37 ˚C; stimulation was quenched after 10 minutes by the addition of ice-cold PBS, centrifugation (300xg, 5 min, 4 ˚C), and subsequent shock-freezing of the cell pellets.
Generation of VAMP7 Knockout in Jurkat Cells
For the generation of sgRNAs the Atum online tool was used (https://www.dna20.com/ eCommerce/cas9/input). The sgRNA oligos were then cloned into the pSpCas9(BB)-2A-GFP (PX458) vector (a kind gift from Feng Zhang [Addgene plasmid # 48138; http://n2t.net/addgene:48138; RRID:Addgene_48138]).
Jurkat T cells (clone E6-1) were passaged to 0.125 Mio cells/ml the day before transfection. 5 Mio cells were resuspended in 100µl OptiMem with 10 µg pSpCas9(BB)-2A-GFP with the sgRNA CACCGCACACCA-AGCATGTTTGGCA and electroplated with a NEPA21 electroporator (Nepagene) with the following settings: 0.2 mm gap electroporation cuvettes, poring pulse: 175 V, length: 5 ms, interval: 50 ms, number: 2, D. rate: 10%, polarity: +. After 48 hours single clones were sorted by FACS for EGFP into 96-well plates. After the cells had recovered and grown the knockout was validated by Western blotting and sequencing.
Lentiviral Transduction of Jurkat Cells
Once the VAMP7 knockout cell line was validated, the re-expression of VAMP7 constructs was performed. Wildtype VAMP7 and mutant VAMP7-C183A, both featuring FLAG tags, were cloned into the lentiviral vector LegoiG2 (a kind gift from Boris Fehse [Addgene plasmid # 27341; http://n2t.net/addgene:27341; RRID:Addgene_27341]) 55 . HEK293 cells were transfected with the constructs FLAG-VAMP7-WT-LegoiG2 or FLAG-VAMP7-C183A-LegoiG2 plus the third-generation packaging plasmids pMDLg/pRRE with pRSV-Rev and phCMV-VSV-G using lipofectamine. Supernatants containing viruses were harvested after 48 hours and concentrated by centrifugation at 10,000xg and 4°C for 4 to 6 hours in glass tubes. VAMP7 knockout Jurkat cells were transduced with the viruses by spinoculation, as described previously 56 . Cells were resuspended in lentiviral supernatant supplemented with Polybrene (6µg/ml) and spun for 90 min at 37°C at a speed of 800xg. After 72 hours the cells were sorted by EGFP expression via FACS. One week later the cells were sorted again for EGFP expression and also for the expression of CD3 and CD28 surface markers.
Construct Design and Cloning
Primary sequences of VAMP7, LAT, DHHC18 and DHHC20 were obtained from UniProt. Full-length constructs of VAMP7 and LAT were engineered bearing His6-and FLAG-tags, while DHHC18 and DHHC20 were designed with FLAG tags alone, and ordered from Geneart. Truncated constructs of DHHC18 were generated by amplifying FLAG-tagged inserts via PCR. Mutagenesis was performed using the QuikChange Site-Directed Mutagenesis system (Agilent). Constructs were then cloned into the pFastBac1 vector of the Bac-to-Bac system (Thermo Fisher).
Insect Cell Expression and Purification
Sf9 insect cells were grown in Sf-900 II medium (Thermo Fisher) at 27 ˚C. Baculoviruses were generated by transfecting insect cells with constructs in the pFastBac1 vector according to the Bac-to-Bac protocol. P4 viral stocks were then used to infect larger cultures, and expressed proteins were harvested 3-5 days following infection (~70-80% cell viability). Cell pellets were shock frozen and lysed in lysis buffer containing 50 mM NaH2PO4 (pH 7.2) (Roth), 300 mM NaCl (Roth), 0.2% Triton X-100 (Roth), 1 mM phenyl methanesulfonyl fluoride (PMSF) (Sigma), cOmplete protease inhibitor cocktail (Roche), and DNase (New England BioLabs) and RNase (Pancreac AppliChem) on ice for 30 minutes. Lysates were cleared by centrifugation (16,000xg, 4 ˚C, 10 min.) and supernatants were loaded onto anti-FLAG M2 affinity gel (Sigma) at 4 ˚C. After washing, proteins were eluted using 0.1 M glycine at pH 3.5 and concentrated using Vivaspin spin filters (VWR) with appropriate MW cut-offs.
After concentration, 0.08% n-dodecyl β-D-maltoside (DDM) (Sigma) and cOmplete protease inhibitor cocktail was added and constructs were dialyzed overnight at 4 ˚C into 50 mM NaH2PO4 (pH 6.5) and 10% glycerol (Roth) .
Protein concentration was determined by BCA assay (Pierce) and expression was confirmed by anti-FLAG Western blot. Purified PATs were extremely sensitive to environmental conditions, precipitating at concentrations greater than ~5-10 µM and losing activity after freezing or 3-5 days storage at 4 ˚C. For this reason, all purified PATs were used immediately for the OPPA assays following dialysis.
Western Blotting
To confirm the stimulation via phosphotyrosine and phospho-ERK1/2, and to confirm expression/purification of constructs expressed in insect cells, lysates were run on SDS-PAGE gels and transferred to nitrocellulose membranes using standard methods. Antibodies used for detection: 4G10 Platinum antiphosphotyrosine (Millipore), anti-pERK (E-4) (Santa Cruz), anti-β-actin (AC-15) (Sigma Aldrich), anti-LAT (Upstate (Millipore)) and anti-FLAG-HRP (Sigma Aldrich). The self-produced VAMP7 antibody was a kind gift of Dr. Andrew Peden (The University of Sheffield, UK).
Acyl Biotin-Exchange
The ABE protocol was followed as described previously 31, 57 . Briefly, stimulated Jurkat SILAC pellets were on ice for 30 minutes. Lysates were cleared by centrifugation (16,100xg, 4 ˚C, 10 min.). Chloroform-methanol (CM) precipitations were used between each chemical labeling step to ensure complete remove of unreacted reagents. The cleared lysates were subjected to a CM precipitation, then resuspended in buffer containing a 50 mM Tris (pH 7.4), 5 mM EDTA, 1% SDS (Roth), 125 mM NaCl, 1 mM PMSF, 0.2% Triton X-100, 20 mM NEM, and PI-cocktail and incubated overnight at 4 ˚C. NEM was then removed by three sequential CM precipitation steps, and enriched samples (e.g. heavy lysates) were resuspended in buffer containing 50 mM Tris (pH 7.4), 5 mM EDTA, 125 mM NaCl, 1% SDS, 574 mM hydroxylamine (HA) (Sigma-Aldrich), 820 µM EZ-Link HPDP-biotin (Thermo), 0.2% Triton X-100, 1 mM PMSF and PI-cocktail; control samples (e.g. light lysates) were resuspended in a similar buffer, omitting HA. After incubation for one hour at room temperature, a single CM precipitation removed HA, and samples were biotinylated in a buffer containing 50 mM Tris (pH 7.4), 5 mM EDTA, 125 mM NaCl, 164 µM EZ-Link HPDP-biotin, 0.2% Triton X-100, 1 mM PMSF and PI-cocktail for one hour at room temperature. Samples were then washed with three sequential CM precipitations and resuspended in buffer containing 50 mM Tris (pH 7.4), 5 mM EDTA, 125 mM NaCl, 0.1% SDS, 0.2% Triton X-100, 1 mM PMSF and PI-cocktail. SILAC-labeled heavy and light samples were then mixed and allowed to bind to streptavidin-agarose beads (Novagen) for 90 min at room temperature. After four sequential washings, biotinylated peptides were eluted by cleaving the HPDP-biotin-cysteine disulfide linkage in a buffer containing 1% beta-mercaptoethanol (2-ME) (Roth) at 37 ˚C for 15 min. Eluates were precipitated via trichloroacetic acid (TCA) precipitation and resuspended in a smaller volume of SDS-PAGE sample buffer containing 0.2% Triton X-100, boiled for 5 min. at 95 ˚C, then run on a 4-12% Bis-Tris gel (NuPAGE Novex). After Coomassie staining, gels were used for in-gel tryptic digestion and subsequent LC-MS/MS. For the stimulated Jurkat cells, four individual ABE enrichments were performed (n=4).
Quantitative LC-MS/MS and Proteomic Data Analysis
Coomassie-stained gel lanes from the ABE enrichment were cut into 30 equal-sized bands and in-gel tryptic digest was performed as described previously 31 the Uniprot human protein database (July 2013). Proteins were filtered with the following criteria: i) not identified only by site, reverse, or known contaminant (MaxQuant), ii) at least one unique peptide, and iii) at least two razor + unique peptides. The unstimulated Jurkat ABE enrichment we published earlier 31 (n=6) was re-analyzed using the following new procedure, allowing direct comparison to the stimulated Jurkat ABE dataset described here (n=4). First, missing values were imputed with the median normalized heavy/light ratio of the specific LC-MS/MS run -in many cases this was very close to 1.0 (representing the background). H/L ratios were then transformed to log2 values and the mean H/L ratio and one-sample t-test p values were calculated. Volcano plots were generated plotting the log2 fold-change to the -log10(p) value, giving rise to a pool of high-confidence palmitoylated proteins.
Enriched pools were analyzed based on three criteria, described previously 31 : i) previous reports in other palmitome studies, ii) predicted palmitoylation sites (CSS-Palm 4.0), and iii) predicted TMDs (TMHMM 2.0) 33,34 .
On-Plate Palmitoylation Assay (OPPA)
Purified targets (VAMP7, LAT) were diluted to 1 µM in buffer containing 50 mM NaH2PO4 (pH 6.5), 500 mM NaCl, 1 mM TCEP and 0.08% DDM. Tween-20 (Sigma-Aldrich) (PBST) using a plate washer (Tecan) and 100 µl of the enzyme mixture was added.
Reactions were carried out at 37 ˚C with shaking for designated time points, and the reaction was quenched by washing with buffer containing 50 mM NaH2PO4 (pH 6.5), 300 mM NaCl, 40 mM NEM and 0.1% Triton X-100.
After the complete time course, plates were washed 4 times with PBST and click chemistry was performed by the addition of 50 µl buffer containing 50 mM NaH2PO4 (pH 6.5), 300 mM NaCl, and 1% Triton X-100. Click chemistry reagents were added as described previously 58 ; briefly, to each 50 µl, the following reagents were added in this order, with vortexing between each step: 1 µl 1 mM biotin-azide (Thermo Fisher) in DMSO (Sigma), 1 µl 50 mM TCEP, 3 µl 16 mM Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (Sigma-Aldrich) prepared in 20% DMSO and 80% t-butanol (Sigma), and 1 µl 50 mM CuSO4 (Sigma). Click chemistry was performed at 37 ˚C for 3 hours with shaking. After washing the plate 6 times with PBST, palmitoylated targets were eluted with 100 µl buffer containing 50 mM NaH2PO4 (pH 6.5), 300 mM NaCl, 1% Triton X-100, 1 mM EDTA and 200 mM imidazole (Roth) for 30 min at 37 ˚C. Eluates were transferred to high-binding plates (Greiner) coated for 3 hr at room temperature with monoclonal anti-FLAG (Sigma-Aldrich) and blocked for 2 hr at room temperature with 3% BSA and allowed to bind overnight at 4 ˚C with shaking. Plates were then washed 6 times with PBST and buffer containing PBS and 0.2 µg/ml Eu 3+ -streptavidin (PerkinElmer) and incubated at room temperature for 1 hour. After 
Immunofluorescence
Coverslips & dishes preparation. 12mmø coverslips (VWR, 631-0666) were pre-coated with 0.02% of poly-L-Lysine for 20 min at room temperature and were washed 3 times in water before being dried and kept for maximum 2 days. 100,000 cells were incubated on coverslips for 30 min in PBS.
Fixation. Cells were fixed with 4% paraformaldehyde (Life Technologies, FB002) for 15 min at room temperature, washed once in PBS and excess of paraformaldehyde was quenched for 10 min with PBS 10 mM glycine (Thermo Fisher Scientific, G8898). Coverslips were kept at 4°C in PBS until permeabilization and staining.
Staining. Cells were permeabilized for 30 min at room temperature with PBS + 0.2% Bovine Serum Albumin (BSA, Euromedex, 04-100-812) and 0.05% Saponin (Sigma-Aldrich, S4521). Cells were then incubated for 1 hour at room temperature with primary antibody, then washed 3 times with PBS 0.2% BSA 0.05% Saponin and incubated protected from light for 20 min in the same buffer with spun secondary antibodies. After washing once with PBS BSA Saponin, and once with PBS, coverslips were soaked three times in PBS, three times in water, and mounted on slides.
Mounting. For regular confocal microscopy, coverslips were mounted with 4-6 µL Fluoromount G (SouthernBiotech, 0100-01) on slides (KNITTEL Starfrost) and dried overnight protected from light before microscope acquisition.
Microscope: Images were acquired with a Leica DmI8 inverted microscope equipped with an SP8 confocal unit using either a 40X (1.35NA) or 63X (1.4NA) objective. Single plane images or Z-stack of images were acquired (pixel size around 60 nm). The short isoform, lacking these TMDs, may be anchored to the membrane via palmitoylation of Cys138, allowing its active site access to the membrane environment required for its activity. C. Schematic representation of the on-plate palmitoylation assay (OPPA). Briefly, the target (VAMP7, featuring both His 6 and FLAG tags) is bound to a Ni-NTA plate. The DHHC PAT is added with clickable PAA-CoA and the reaction is quenched at specific time points using NEM. Biotin is subsequently clicked on to the PAA-modified target, VAMP7 is eluted and then bound to a anti-FLAG plate. Streptavidin-Eu 3+ can then be used to quantify palmitoylated VAMP7, and a steady-state slope can be calculated. D. Results of OPPA experiments of VAMP7-WT and VAMP7-C183A, palmitoylated by constructs of DHHC18 and DHHC20 (n ≥ 12, geometric mean +/-SEM shown). 
Analysis of VAMP7 colocalization with
